Connect with us

Medical Research

New Duke Medical Center Study Draws Alarming Genetic Linkages to Men’s Marijuana Use

Published

on

New Duke Medical Center Study Draws Alarming Genetic Linkages to Men’s Marijuana Use

A Duke Medical Center study suggests that cannabis use may mark a man’s sperm epigenetically for autism. The study engaged 24 men and 15 rats to outline the possibility of transgenerational effects of marijuana use. The exposure of men’s sperms to DLGAP2, a gene associated with autism, resulted in accumulation of epigenetic marks.

Associate professor of obstetrics and gynecology Susan Murphy, Ph.D., led the team of scientists who found substantial hypomethylation in DLGAP2 in sperm from marijuana using men compared to those who didn’t. The rats in the study were exposed to tetrahydrocannabinol (THC) with similar results.

The journal Epigenetics featured the study on August 26 in an article that stated that the scientists had successfully authenticated the differential hypomethylation in the autism-related gene.

After quoting the specifics concerning the men and rats in the study, the report concluded that there was a necessity to conduct further studies before confirming whether marijuana has no adverse side effects.

Michael is a freelance writer with several years of experience in writing of all kinds. From the uber-technical to the more relaxed, he is well-versed in a variety of styles. Lately, his work has been primarily focused on the CBD industry—a market with which he has a particular background and interest. Michael has an extensive interest and experience in legal research for the CBD market, and he has a knack for well-researched pieces and guides for the growing CBD and medicinal cannabis community.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.